- Home
- CLW vs ACHV Comparison
CLW vs ACHV Comparison
Compare CLW & ACHV Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | CLW | ACHV |
|---|---|---|
| Founded | 2005 | N/A |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Paper | Biotechnology: In Vitro & In Vivo Diagnostic Substances |
| Sector | Basic Materials | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 288.5M | 239.0M |
| IPO Year | N/A | N/A |
Fundamental Metrics
Financial Performance| Metric | CLW | ACHV |
|---|---|---|
| Price | $18.29 | $5.57 |
| Analyst Decision | Buy | Strong Buy |
| Analyst Count | 3 | 2 |
| Target Price | ★ $27.00 | $15.50 |
| AVG Volume (30 Days) | 198.0K | ★ 709.9K |
| Earning Date | 02-12-2026 | 03-10-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | ★ 875.72 | N/A |
| EPS | ★ 8.63 | N/A |
| Revenue | ★ $1,556,100,000.00 | N/A |
| Revenue This Year | $13.91 | N/A |
| Revenue Next Year | N/A | N/A |
| P/E Ratio | $2.08 | ★ N/A |
| Revenue Growth | ★ 23.00 | N/A |
| 52 Week Low | $16.44 | $1.84 |
| 52 Week High | $33.57 | $6.03 |
Technical Indicators
Market Signals| Indicator | CLW | ACHV |
|---|---|---|
| Relative Strength Index (RSI) | 45.29 | 60.73 |
| Support Level | $17.69 | $5.12 |
| Resistance Level | $18.72 | $6.03 |
| Average True Range (ATR) | 0.82 | 0.33 |
| MACD | -0.16 | 0.00 |
| Stochastic Oscillator | 19.94 | 59.11 |
Price Performance
Historical ComparisonAbout CLW Clearwater Paper Corporation
Clearwater Paper Corp is engaged in the manufacturing and supplier of Solid Bleached Sulfate (SBS) paperboard packaging products. The company products includes: SBS paperboard which is a premium paperboard grade that is frequently used to produce folding cartons, food service, commercial printing items. It generates maximum revenue from Pulp and Paperboard segment. Company operate in United States and have globalized access too. Geographically, it derives maximum revenue from the United States.
About ACHV Achieve Life Sciences Inc.
Achieve Life Sciences Inc is a specialty pharmaceutical company committed to advancing cytisinicline as a widely available treatment option to help people battling nicotine addiction. It is an established smoking cessation treatment that has been approved and marketed in Central and Eastern Europe. Achieve's focus is to address the smoking health epidemic through the development and commercialization of cytisinicline. It has one operating segment, dedicated to the development and commercialization of cytisinicline for niceon.